Canadian cannabis company
The company has faced earnings deficits and is likely to have continued pressures from supply-chain issues and increased competition, S&P Global Ratings analysts
Canopy “significantly” underperformed S&P’s expectations in the 2022 fiscal year as consumer tastes for premium products evolved, the analysts wrote. During the last fiscal year, the company didn’t have enough inventory to meet demand for select strains and high-potency ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.